dactinomycin has been researched along with catechin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, JJ; Kashiwada, Y; Lee, KH; Nishioka, I; Nonaka, G | 1 |
| Abou-Agag, LH; Aikens, ML; Benza, RL; Booyse, FM; Grenett, HE; Shows, SR; Tabengwa, EM | 1 |
| Kim, J; Paulson, KE; Rieger-Christ, KM; Summerhayes, IC; Wazer, DE; Yee, AS; Zhang, X | 1 |
| Kalinovsky, T; Monterrey, J; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Genç, H; Sinan Özalp, S; Tansu Koparal, A; Tasa, BA; Telli, E | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
7 other study(ies) available for dactinomycin and catechin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antitumor agents, 129. Tannins and related compounds as selective cytotoxic agents.
Topics: Antineoplastic Agents, Phytogenic; Biflavonoids; Catechin; Cell Survival; Plants, Medicinal; Proanthocyanidins; Tannins; Tumor Cells, Cultured | 1992 |
Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.
Topics: Catechin; Cells, Cultured; Dactinomycin; Endothelium, Vascular; Fibrinolysis; Flavonoids; Gene Expression; Humans; Luciferases; Nucleic Acid Synthesis Inhibitors; Phenols; Polymers; Promoter Regions, Genetic; Quercetin; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tissue Plasminogen Activator; Transfection; Umbilical Veins; Urokinase-Type Plasminogen Activator | 2001 |
Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
Topics: Blotting, Western; Breast Neoplasms; Catechin; Cell Line; Cell Line, Tumor; Cell Movement; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, Reporter; High Mobility Group Proteins; Humans; Models, Biological; Phosphorylation; Plasmids; Proto-Oncogene Proteins c-myc; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Signal Transduction; Tea; Time Factors; Transcription, Genetic; Transfection; Wnt Proteins | 2006 |
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Carcinogens; Catechin; Cell Line, Tumor; Chondrosarcoma; Dactinomycin; Dexamethasone; Doxycycline; Fibrosarcoma; Humans; Interleukin-1beta; Lipopolysaccharides; Liposarcoma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Sarcoma; Sarcoma, Synovial; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Necrosis Factor-alpha | 2013 |
In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Catechin; Cell Line, Tumor; Choriocarcinoma; Dactinomycin; Enzyme Activation; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Receptor, ErbB-2; RNA, Messenger | 2017 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |